Skip to content

Marissa Raymond-Flesch

5 papers in the library · 47 citations · publishing 2023-2026

Papers

Sort Most recent Most cited

Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care.

Current Psychiatry Reports May 14, 2026 Jamarie Geller, Rachel M Pacilio, Amanda E. Downey et al.

There is growing evidence that psychedelics and associated treatment modalities may offer therapeutic benefits across a range of psychiatric conditions. Anorexia nervosa (AN), a serious and often treatment-resistant illness associated with significant morbidity and mortality, is one such condition for which psilocybin-assisted therapy (PAT) may hold promise. To date, research on PAT for AN has...

Leveraging family and caregiver support in psychedelic-assisted therapy: considerations for the treatment of adolescents.

Child and Adolescent Psychiatry and Mental Health June 4, 2025 Sarah Forsberg, Amanda E. Downey, Lindsey D Bruett et al. 5 citations

Psychedelic-assisted therapy (PAT) is gaining recognition as a promising intervention for treatment-refractory mental health conditions in adults. While interest in its applications for adolescents is growing, critical gaps remain in understanding safe and effective delivery of PAT to this vulnerable population, including implications for caregiver/family (used interchangeably) involvement in...

A systematic review of participant diversity in psychedelic-assisted psychotherapy trials.

Psychiatry Research March 1, 2025 Stephanie L. Haft, Amanda E. Downey, Marissa Raymond-Flesch et al. 22 citations

A lack of diverse and representative participant samples in mental health intervention research perpetuates mental health disparities. This issue has become a salient concern in studies of psychedelic-assisted psychotherapy (PAT), which is emerging as a promising mental health intervention. This systematic review evaluates the reporting, representation, and analysis of participant...

Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.

Journal of Eating Disorders April 24, 2024 Amanda E. Downey, Anita V. Chaphekar, Joshua Woolley et al. 13 citations

Clinical trials using psilocybin therapy to treat anorexia nervosa (AN) are currently underway. The safety and tolerability of psilocybin is of utmost importance in individuals with AN who may present unique medical vulnerabilities. The purpose of this review is to describe how the common physiologic adverse effects of psilocybin may impact medical complications experienced by individuals with...

“But the reality is it's happening”: A qualitative study of eating disorder providers about psilocybin‐assisted psychotherapy

International Journal of Eating Disorders August 8, 2023 Maxine Boyd, Joshua Woolley, Amanda E. Downey et al. 7 citations

Abstract Objective This study invited providers who care for patients with eating disorders to inform engagement, communication, and collaboration with psilocybin‐assisted psychotherapy interventions. Method Medical and mental health providers who treat patients with eating disorders were recruited via professional referral networks and participant driven sampling from across California to...